Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 1
R&D Momentum
56/100
Pipeline Velocity
37/100
Trial Completion Rate
90/100
Pipeline Concentration
56/100
Pipeline Freshness
94/100
Strategic Signals
Activity
Last 14 days
The Effect of Superficial Cervical Block Application on Postoperative Opioid Consumption in Patients Undergoing Anterior Cervical Discectomy Surgery
The Effects of Mulligan and Proprioceptive Neuromuscular Facilitation Techniques on Pain, Functionality, Proprioception, and Quality of Life in Individuals With Rotator Cuff Lesions
The Effect of Developmental Support Provided to Mothers of Infants/Children Diagnosed With Spinal Muscular Atrophy (SMA) on the Development of Their Infants/Children and on Mothers' Developmental Knowledge
The Effects of Cognitive Task-Based Walking Exercise on Cognitive Function, Depression, Sleep Quality, and Quality of Life in Older Adults With Brain Fog: A Randomized Controlled Trial
THE EFFECT OF L-THEANINE SUPPLEMENTATION ON REM SLEEP BEHAVIOR DISORDER, GASTROINTESTINAL FUNCTION, AND INFLAMMATORY MARKERS IN PARKINSON'S DISEASE
Comparison of the Structured FEMOB Mobilization Technique and the MOPEXE Exercise Model in Women With Primary Dysmenorrhea
Investigation Of The Effectiveness Of Acupuncture In Patients Diagnosed With Treatment-resistant Interstitial Cystitis/Bladder Pain Syndrome
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)